Trial Details
TERMINATEDBasic Information
| Clinical ID | c3193 |
|---|---|
| Identifier | NCT02413047 |
| Trial Title | Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Disease|Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Azathioprine|DRUG: 6 mercaptopurine|DRUG: Methotrexate |
Participant Information
| Sponsor | Indiana University |
|---|---|
| City | Indianapolis |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2015-05 |
|---|---|
| Primary Completion Date | 2018-02 |
| Completion Date | 2018-02 |